Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 22 of 22 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 07/27/21
End: 12/25/23
Due: 12/25/24
Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine
Phase: N/A
Priority: Normal
Start: 03/23/21
End: 05/28/21
Due: 05/28/22
Phase: N/A
Priority: Normal
Start: 08/17/21
End: 12/13/21
Due: 12/13/22
Phase: N/A
Priority: Normal
Start: 11/05/21
End: 07/14/22
Due: 07/14/23
Phase: N/A
Priority: Normal
Start: 01/08/22
End: 12/30/22
Due: 12/30/23
Phase: N/A
Priority: Normal
Start: 06/05/21
End: 08/31/23
Due: 08/31/24
Phase: N/A
Priority: Normal
Start: 05/11/21
End: 11/30/21
Due: 11/30/22
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 03/09/23
Due: 03/09/24
Phase: N/A
Priority: Normal
Start: 09/10/21
End: 05/31/23
Due: 05/31/24
Phase: N/A
Priority: Normal
Start: 07/09/21
End: 01/31/22
Due: 01/31/23
Phase: N/A
Priority: Normal
Start: 10/31/20
End: 05/31/21
Due: 05/31/22
Phase: N/A
Priority: Normal
Start: 01/04/24
End: 07/21/25
Due: 07/21/26
Phase: N/A
Priority: Normal
Start: 07/30/22
End: 02/15/23
Due: 02/15/24
Phase: N/A
Priority: Normal
Start: 10/31/20
End: 02/08/23
Due: 02/08/24
Phase: N/A
Priority: Normal
Start: 06/19/21
End: 12/19/21
Due: 12/19/22
Phase: N/A
Priority: Normal
Start: 12/15/22
End: 01/15/23
Due: 01/15/24
Phase: N/A
Priority: Normal
Start: 02/10/22
End: 03/10/22
Due: 03/10/23
Phase: N/A
Priority: Normal
Start: 12/20/22
End: 08/20/23
Due: 08/20/24
Phase: N/A
Priority: Normal
Start: 04/16/20
End: 07/24/21
Due: 07/24/22
Phase: N/A
Priority: Normal
Start: 11/27/21
End: 01/27/23
Due: 01/27/24
Phase: N/A
Priority: Normal
Start: 02/20/23
End: 02/20/23
Due: 02/20/24